Sionna Therapeutics Analyst Price Targets - Benzinga

SPY778.57+0.60%QQQ751.38+0.51%BTC/USD83,627.35+0.85%DIA516.21+0.89%GLD384.50+1.55%TLT77.97+0.12%

Sionna Therapeutics Inc

SIONNASDAQ

Trade with Public

Trade with Public

$4.90

N/A

Last update: Oct 9, 4:00 PM

Overview News Earnings Forecast EventsPrice TargetsFinancials Sentiment Ownership Compare Options Stock Report

Connect With Us

About Benzinga

Market Resources

Trading Tools & Education

Ring the Bell

© 2026 Benzinga | All Rights Reserved

Sionna Therapeutics Analyst Price Targets

Wall Street analyst price targets and consensus rating for Sionna Therapeutics (SION).

Price Target Range — 6 Quarters

Analyst Consensus — 10 Analysts

2S.Buy

3Buy

4Hold

1Sell

Consensus RatingBuy# Analysts10Avg. Consensus PT$44Upside to Avg. PT+803.1%

Rating Trend — Last 9 Months

Recent Analyst Actions

See all ratings →

Date	Firm	Analyst	Action	Rating Change	Price Target
Sep 15, 2026	Wedbush	Laura Chico	PT Raise	Neutral	$5→$6
Aug 11, 2026	Guggenheim	Yatin Suneja	Downgrade	Buy→Neutral	—
Aug 11, 2026	Wedbush	Laura Chico	Downgrade	Outperform→Neutral	$53→$5
Aug 10, 2026	BTIG	Kambiz Yazdi	Downgrade	Buy→Neutral	—
Aug 7, 2026	Guggenheim	Yatin Suneja	PT Raise	Buy	$50→$60
May 26, 2026	Citizens	Jonathan Wolleben	Maintained	Market Outperform	$63
May 20, 2026	Freedom Broker	Ilya Zubkov	Downgrade	Buy→Hold	$38
May 18, 2026	Stifel	Paul Matteis	PT Raise	Buy	$44→$55
May 13, 2026	BTIG	Kambiz Yazdi	Maintained	Buy	$58
May 5, 2026	Wedbush	Laura Chico	Initiate	Outperform	$53
Apr 28, 2026	Jones Trading	Debanjana Chatterjee	PT Raise	Buy	$52→$63
Apr 27, 2026	BTIG	Kambiz Yazdi	Maintained	Buy	$58
Mar 3, 2026	Guggenheim	Yatin Suneja	PT Raise	Buy	$45→$50
Mar 2, 2026	BTIG	Kambiz Yazdi	Maintained	Buy	$58
Feb 24, 2026	Citizens	Jonathan Wolleben	Initiate	Market Outperform	$63
Jan 14, 2026	BTIG	Kambiz Yazdi	Maintained	Buy	$58
Jan 7, 2026	BTIG	Kambiz Yazdi	PT Raise	Buy	$50→$58
Dec 23, 2025	LifeSci Capital	Cory Jubinville	Initiate	Outperform	$60
Dec 1, 2025	RBC Capital	Brian Abrahams	Downgrade	Sector Perform→Underperform	$24
Nov 19, 2025	BTIG	Kambiz Yazdi	Initiate	Buy	$50

More with Benzinga EdgeGet Access

Analyst Ratings News

PRO
Wedbush Maintains Neutral on Sionna Therapeutics, Raises Price Target to $6

Wedbush analyst Laura Chico maintains Sionna Therapeutics (NASDAQ:SION) with a Neutral and raises the price target from $5 to $6.

Benzinga Newsdesk

PRO
Guggenheim Downgrades Sionna Therapeutics to Neutral

Guggenheim analyst Yatin Suneja downgrades Sionna Therapeutics (NASDAQ:SION) from Buy to Neutral.

Benzinga Newsdesk

PRO
Wedbush Downgrades Sionna Therapeutics to Neutral, Lowers Price Target to $5

Wedbush analyst Laura Chico downgrades Sionna Therapeutics (NASDAQ:SION) from Outperform to Neutral and lowers the price target from $53 to $5.

Benzinga Newsdesk

PRO
Guggenheim Maintains Buy on Sionna Therapeutics, Raises Price Target to $60

Guggenheim analyst Yatin Suneja maintains Sionna Therapeutics (NASDAQ:SION) with a Buy and raises the price target from $50 to $60.

Benzinga Newsdesk

PRO
Citizens Reiterates Market Outperform on Sionna Therapeutics, Maintains $63 Price Target

Citizens analyst Jonathan Wolleben reiterates Sionna Therapeutics (NASDAQ:SION) with a Market Outperform and maintains $63 price target.

Benzinga Newsdesk

PRO
Stifel Maintains Buy on Sionna Therapeutics, Raises Price Target to $55

Stifel analyst Paul Matteis maintains Sionna Therapeutics (NASDAQ:SION) with a Buy and raises the price target from $44 to $55.

Benzinga Newsdesk